Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway.

[1]  M. Loda,et al.  Elevated Serum Periostin Levels in Patients with Bone Metastases from Breast but not Lung Cancer , 2003, Breast Cancer Research and Treatment.

[2]  Gerhard Christofori,et al.  Molecular Mechanisms of Tumor Angiogenesis and Tumor Progression , 2000, Journal of Neuro-Oncology.

[3]  M. Melhem,et al.  FHIT protein expression and its relation to apoptosis, tumor histologic grade and prognosis in colorectal adenocarcinoma: An immunohistochemical and image analysis study , 2004, Clinical & Experimental Metastasis.

[4]  R. Hynes.  Metastatic Potential Generic Predisposition of the Primary Tumor or Rare, Metastatic Variants—Or Both? , 2003, Cell.

[5]  D. Bigner,et al.  Bone-related Genes Expressed in Advanced Malignancies Induce Invasion and Metastasis in a Genetically Defined Human Cancer Model* , 2003, The Journal of Biological Chemistry.

[6]  Robert A. Weinberg,et al.  Taking the Study of Cancer Cell Survival to a New Dimension , 2002, Cell.

[7]  J. Folkman.  Role of angiogenesis in tumor growth and metastasis. , 2002, Seminars in oncology.

[8]  Ruth Katz,et al.  Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. , 2002, Cancer research.

[9]  Martin A. Nowak,et al.  The role of chromosomal instability in tumor initiation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[10]  P. Falb,et al.  A Novel Quality Control Slide for Quantitative Immunohistochemistry Testing , 2002, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[11]  C. Bucana,et al.  Lipopolysaccharide‐induced metastatic growth is associated with increased angiogenesis, vascular permeability and tumor cell invasion , 2002, International journal of cancer.

[12]  David A. Cheresh,et al.  Get a ligand, get a life: integrins, signaling and cell survival , 2002, Journal of Cell Science.

[13]  I. Macdonald,et al.  Cancer spread and micrometastasis development: Quantitative approaches for in vivo models , 2002, BioEssays : news and reviews in molecular, cellular and developmental biology.

[14]  D. Fishman,et al.  Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility. , 2002, Cancer research.

[15]  Sophie Lelièvre,et al.  beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. , 2002, Cancer cell.

[16]  I. Macdonald,et al.  Metastasis: Dissemination and growth of cancer cells in metastatic sites , 2002, Nature Reviews Cancer.

[17]  M. Blasco.  Telomerase beyond telomeres , 2002, Nature Reviews Cancer.

[18]  K. M. Nicholson,et al.  The protein kinase B/Akt signalling pathway in human malignancy. , 2002, Cellular signalling.

[19]  W. Hahn,et al.  Modelling the molecular circuitry of cancer , 2002, Nature Reviews Cancer.

[20]  J. Willis,et al.  Focus on colon cancer. , 2002, Cancer cell.

[21]  G. Naumov,et al.  Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy. , 2002, Cancer research.

[22]  S. Bogen,et al.  Synthetic peptides identified from phage-displayed combinatorial libraries as immunodiagnostic assay surrogate quality-control targets. , 2002, Clinical chemistry.

[23]  C. Giachelli,et al.  The alpha(v)beta3 integrin, NF-kappaB, osteoprotegerin endothelial cell survival pathway. Potential role in angiogenesis. , 2002, Trends in cardiovascular medicine.

[24]  D. Fishman,et al.  Periostin Secreted by Epithelial Ovarian Carcinoma Is a Ligand for V 3 and V 5 Integrins and Promotes Cell Motility 1 , 2002 .

[25]  R. Abraham.  Cell cycle checkpoint signaling through the ATM and ATR kinases. , 2001, Genes & development.

[26]  O. Volpert,et al.  In vivo mechanisms by which tumors producing thrombospondin 1 bypass its inhibitory effects. , 2001, Genes & development.

[27]  Elise C. Kohn,et al.  The microenvironment of the tumour–host interface , 2001, Nature.

[28]  R. Khokha,et al.  Anoikis and metastatic potential of cloudman S91 melanoma cells. , 2001, Cancer research.

[29]  Christopher W. Wong,et al.  Apoptosis: an early event in metastatic inefficiency. , 2001, Cancer research.

[30]  R. L. Baldwin,et al.  Differential gene expression between normal and tumor-derived ovarian epithelial cells. , 2000, Cancer research.

[31]  Shaomeng Wang,et al.  3-(Hydroxymethyl)-bearing phosphatidylinositol ether lipid analogues and carbonate surrogates block PI3-K, Akt, and cancer cell growth. , 2000, Journal of medicinal chemistry.

[32]  R. DePinho,et al.  Mice without telomerase: what can they teach us about human cancer? , 2000, Nature Medicine.

[33]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[34]  L. Bianchi,et al.  HIF-1-mediated activation of transferrin receptor gene transcription by iron chelation. , 1999, Nucleic acids research.

[35]  Lynda F. Bonewald,et al.  Identification and Characterization of a Novel Protein, Periostin, with Restricted Expression to Periosteum and Periodontal Ligament and Increased Expression by Transforming Growth Factor β , 1999 .

[36]  W. Yung,et al.  Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN. , 1999, Cancer research.

[37]  P. Brodt,et al.  Liver in Response to Metastatic Tumor Cells Rapid Induction of Cytokine and E-Selectin Expression in the Updated Version , 1999 .

[38]  X. Shen,et al.  The mammalian Rad24 homologous to yeast Saccharomyces cerevisiae Rad24 and Schizosaccharomyces pombe Rad17 is involved in DNA damage checkpoint. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[39]  K. Luzzi,et al.  Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. , 1998, The American journal of pathology.

[40]  M. Schwartz,et al.  Integrins, adhesion and apoptosis. , 1997, Trends in cell biology.

[41]  R H Hruban,et al.  Gene expression profiles in normal and cancer cells. , 1997, Science.

[42]  S. Fox,et al.  Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. , 1996, European journal of cancer.

[43]  D. Cheresh,et al.  Requirement of vascular integrin alpha v beta 3 for angiogenesis. , 1994, Science.

[44]  R. Kikuno,et al.  Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I. , 1993, The Biochemical journal.

[45]  K. Mafune,et al.  Increased expression of human ribosomal phosphoprotein P0 messenger RNA in hepatocellular carcinoma and colon carcinoma. , 1992, Cancer research.

[46]  L. Weiss,et al.  Metastatic inefficiency. , 1990, Advances in cancer research.

[47]  C. Goodman,et al.  Sequence analysis and neuronal expression of fasciclin I in grasshopper and drosophila , 1988, Cell.

[48]  J Salvage,et al.  A matter of life and death. , 1981, Nursing times.